Product Information
AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB is a generic product labeled by Strides Pharma Inc., priced at $6.0888 per EA under NDC 64380020001. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Jun 1, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB
amlodipine besylate valsartan hydrochlorothiazideStrength
10; 25; 160 mg/1; mg/1; mg/1
Manufacturer
Strides Pharma Inc.NDC
64380020001
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTANApproval Type
Generic (ANDA)
FDA Application
ANDA201087FDA Approved
6/1/2015
TE Code
AB
On Market Since
6/27/2022
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB has been published 129 times since Apr 17, 2024, and over the history we have for it it has declined 16.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.0888 per EA |
|---|---|
| All-time high | $8.3788 (Oct 15, 2025) |
| All-time low | $5.9684 (Jul 22, 2026) |
| 52-week high | $8.3788 |
| 52-week low | $5.9684 |
| Median price | $7.3220 |
| Average price | $7.3474 |
| Largest weekly change | -6.8% (May 20, 2026) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the amlodipine besylate valsartan hydrochlorothiazide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strides Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
amlodipine besylate valsartan hydrochlorothiazide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB, manufactured by Strides Pharma Inc., is $6.0888 per EA (NDC 64380020001), effective Sep 30, 2026.
How has the price of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB has declined 16.8%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB?
Since Apr 17, 2024, the NADAC for AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB has ranged from a low of $5.9684 (Jul 22, 2026) to a high of $8.3788 (Oct 15, 2025), with a median of $7.3220 per EA.
Are there cheaper alternatives to AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB?
AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 10-160-25 MG TAB (NDC 64380020001) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.